Ancora Heart kicked off a European clinical study for its device designed to directly repair an enlarged left ventricle from the inside, as a treatment for patients suffering from heart failure. The ...

Pivotal Trial to Evaluate Safety and Efficacy of AccuCinch® Ventricular Restoration System in Heart Failure Patients with Reduced Ejection Fraction SANTA CLARA, Calif.--(BUSINESS WIRE)--Ancora Heart, ...

Please provide your email address to receive an email when new articles are posted on . People whose sedentary time rose from age 11 to 24 years were more likely to have a progressively enlarged left ...

About Ancora Heart Ancora Heart, Inc., based in Santa Clara, Calif., is dedicated to helping people with heart failure feel better and live longer. Ancora Heart has developed the AccuCinch Ventricular ...

Please provide your email address to receive an email when new articles are posted on . Ancora Heart Inc. announced that the FDA granted breakthrough device designation to its transcatheter left ...

PROVIDENCE, R.I. -The Miriam Hospital is actively recruiting local participants for a U.S. clinical trial of the Parachute device for treating heart failure. The study is focused on determining if the ...

Idiopathic premature ventricular contractions (PVCs) may cause subtle changes in left atrium (LA) structure and function. The authors of an article published in Cardiovascular Innovations and ...

A gene that can cause the heart to become enlarged, greatly increasing the risk of heart attacks and heart failure, is identified today in a new study. A gene that can cause the kidney to become ...

Regular cannabis use could affect the structure and function of the heart. Regular cannabis use could affect the structure and function of the heart, research led by a team at Queen Mary University of ...